Can Subcutaneous IgG Therapy Provide Rapid and Sufficient Serum IgG Levels in Initiation and High Dose Maintenance Settings?

Subcutaneous IgG (SCIG) provides stable serum IgG levels, has fewer systemic adverse events than intravenous IgG (IVIG) and is convenient for home therapy.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2010-02, Vol.125 (2), p.AB139-AB139
Main Authors: Orange, J.S, Stein, M.R, Longhurst, H.L, Borte, M, Ritchie, B, Sturzenegger, M.H, Jolles, S, Berger, M
Format: Article
Language:English
Subjects:
Allergy and Immunology
Immune system
Medical research
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Subcutaneous IgG (SCIG) provides stable serum IgG levels, has fewer systemic adverse events than intravenous IgG (IVIG) and is convenient for home therapy.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2009.12.545